纤维化
肾
线粒体
细胞生物学
癌症研究
生物
糖酵解
医学
病理
内分泌学
新陈代谢
作者
Hao Huang,Yuanyuan Han,Yan Zhang,Jianhua Zeng,Xin He,Jiawei Cheng,Songkai Wang,Yiwei Xiong,Hongling Yin,Qiongjing Yuan,Ling Huang,Yanyun Xie,Jie Meng,Lijian Tao,Zhangzhe Peng
标识
DOI:10.1002/advs.202408753
摘要
Abstract Renal fibrosis is a common pathway involved in the progression of various chronic kidney diseases to end‐stage renal disease. Recent studies show that mitochondrial injury of renal tubular epithelial cells (RTECs) is a crucial pathological foundation for renal fibrosis. However, the underlying regulatory mechanisms remain unclear. Pyruvate carboxylase (PC) is a catalytic enzyme located within the mitochondria that is intricately linked with mitochondrial damage and metabolism. In the present study, the downregulation of PC in various fibrotic animal and human kidney samples is demonstrated. Renal proximal tubule–specific Pcx gene knockout mice ( Pcx cKO ) has significant interstitial fibrosis compared to control mice, with heightened expression of extracellular matrix molecules. This is further demonstrated in a stable PC knock‐out RTEC line. Mechanistically, PC deficiency reduces its interaction with sulfide:quinone oxidoreductase (SQOR), increasing the ubiquitination and degradation of SQOR. This leads to mitochondrial morphological and functional disruption, increased mtDNA release, activation of the cGAS‐STING pathway, and elevated glycolysis levels, and ultimately, promotes renal fibrosis. This study investigates the molecular mechanisms through which PC deficiency induces mitochondrial injury and metabolic reprogramming in RTECs. This study provides a novel theoretical foundation and potential therapeutic targets for the pathogenesis and treatment of renal fibrosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI